Abstract:
OBJECTIVE To identify the absorbed components of the Mongolian medicine Caoguo Qiwei Decoction and elucidate its potential mechanism of action against insomnia through network pharmacology and animal experiments.
METHODS LC-MS/MS technology was employed to identify the chemical constituents and absorbed components of the decoction. Based on this, the TCMSP, SwissTargetPrediction, GeneCards, and OMIM databases were used to screen for component-related and insomnia-related targets. The intersection of these two sets yielded anti-insomnia targets. Protein-protein interaction networks were constructed using the STRING database. A drug-active component-target-pathway network was established using Cytoscape 3.10.0 software. GO functional and KEGG pathway enrichment analyses were performed using the Metascape platform to predict the mechanism of action of Caoguo Qiwei Decoction in treating insomnia. To evaluate its anti-insomnia efficacy, SD rats were divided into 4 groups: a normal control group, a model group, a Caoguo Qiwei Decoction group, and a positive control group. The insomnia model was established via intraperitoneal injection of para-chlorophenylalanine. After 7 d of intragastric administration, open-field tests were conducted to assess the general status and behavioral changes. Serum and brain tissue levels of gamma-aminobutyric acid(GABA) and dopamine(DA) were measured in each group using LC-MS/MS. The mRNA expression levels of D2 dopamine receptor(DRD2), GABRA2 and GABRB3 in rat brain tissues were detected by RT-qPCR.
RESULTS A total of 47 absorbed components were identified in Caoguo Qiwei Decoction. Network pharmacology predicted that key components such as pteryxin and dihydroartemisinin might act on 193 common targets, including GABRB3 and ADORA2A, and exert potential effects by regulating signaling pathways such as neuroactive ligand-receptor interactions and serotonergic synapses. Pharmacodynamic experiments demonstrated that the decoction significantly ameliorated behavioral abnormalities in rats with insomnia, elevated GABA and reduced DA levels in brain tissue and serum(P<0.05). RT-qPCR results showed that the decoction could significantly downregulate the mRNA expression of DRD2(P<0.05) and markedly upregulate the mRNA levels of GABRA2 and GABRB3(P<0.05) in rat brain tissues.
CONCLUSION This study preliminarily clarified the absorbed components and potential mechanism of action of Caoguo Qiwei Decoction, providing a reference for further research on its pharmacological mechanism.